Multiple putative cellular and mitochondrial targets

This entry represents a classification for therapeutic agents whose specific molecular targets are either not fully characterized or involve a broad range of cellular and mitochondrial components. Such agents often exert their effects by modulating mitochondrial bioenergetics, such as the electron transport chain or the mitochondrial permeability transition pore, rather than binding to a single receptor or enzyme (Murphy & Smith, 2007, "Targeting antioxidants to mitochondria by conjugation to lipophilic cations"). Because these interactions are often non-specific or involve multiple low-affinity sites, they are categorized under "multiple putative targets" in pharmacological databases like ChEMBL or DrugBank. This polypharmacological approach is common in the treatment of mitochondrial diseases and oxidative stress-related disorders, where systemic metabolic support is required. For example, compounds like idebenone are thought to function as alternative electron carriers, bypassing deficiencies in Complex I to restore ATP production (Haefeli et al., 2011, "Idebenone rapidly restores ATP levels in cells with mitochondrial DNA mutations"). However, the lack of a singular target complicates the precise determination of pharmacokinetics and the prediction of off-target toxicities, posing significant challenges for safety assessment (Gueven et al., 2021, "Idebenone: A review of its clinical efficacy and safety").

Other names

Multiple cellular targetsUnspecified mitochondrial targetsPutative mitochondrial targetsMitochondrial respiratory chain targets

Modulation of mitochondrial electron transport, reduction of oxidative stress, and stabilization of mitochondrial membrane potential through non-specific or multi-target interactions.